Korean J Med > Volume 76(2); 2009 > Article
The Korean Journal of Medicine 2009;76(2):215-219.
Long-term survival in a case of hepatocellular carcinoma with portal vein thrombosis treated with transarterial chemoembolization
Kwan Sik Park, Eun Hee Seo, Hyun Seok Lee, So Young Choi, Chang Min Cho, Won Young Tak, Young Oh Kweon
간문맥혈전을 동반한 간암의 화학색전술 후 장기생존 1예
박관식 &#; 서은희 &#; 이현석 &#; 최소영 &#; 조창민 &#; 탁원영 &#; 권영, Eun Hee Seo, Hyun Seok Lee, So Young Choi, Chang Min Cho, Won Young Tak, Young Oh Kweon
Abstract
Hepatocellular carcinoma (HCC) is the third most common malignancy in Korea and the prognosis of patients with HCC is generally poor. Most patients with HCC have unresectable disease at presentation and only a small proportion of patients diagnosed early receive curative treatment. Transarterial chemoembolization (TACE) is a widely used palliative treatment for advanced HCC and its prognostic benefit has been proven in several studies. TACE is contraindicated for patients with portal vein tumor thrombosis (PVT) because it carries a potential risk of acute hepatic failure. Recently, however, a few studies have provided evidence of a survival benefit after TACE in patients with PVT if they have good hepatic reserve and collateral circulation around the portal trunk. We experienced a case of HCC with PVT, with long-term survival and no evidence of recurrence or hepatic failure after TACE, and present this case with a review of the relevant literature. (Korean J Med 76:215-219, 2009)
Key Words: Hepatocellular Carcinoma; Portal vein; Thrombosis; Therapeutic Chemoembolization


TOOLS
METRICS Graph View
  • 1,271 View
  • 10 Download

Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2024 by The Korean Association of Internal Medicine.

Developed in M2PI

Close layer
prev next